Three out of four U.S. adults support the use of emerging technologies that estimate a future child's likelihood of developing health conditions influenced by multiple genes—such as diabetes, heart ...

What if you could screen embryos for diseases before they became babies? What if you had the power to choose the traits your baby would have? Would you use it? These practically polar opposite ...

Biotech start-up Orchid is one of the few companies offering in-vitro fertilisation (IVF) patients the option to screen their embryos for severe genetic diseases before their pregnancy begins. "This ...

A new global review shows that countries are taking very different approaches to regulating polygenic embryo testing. For more than four decades, in vitro fertilization (IVF) has helped families have ...

Please provide your email address to receive an email when new articles are posted on . More research is needed for preimplantation genetic testing for polygenic disorders. Now, it cannot account for ...

A U.S.-based biotech company has announced the launch of Nucleus Embryo, a company that screens human embryos for desired genetic profiles, a practice the Catholic Church teaches violates human ...

A human embryo embeds itself into a fake uterus created by researchers. Screenshot from an Institute for Bioengineering of Catalonia video Sixty percent of miscarriages are caused by the failure of an ...

About 100,000 babies were born through in vitro fertilization in 2024, according to the most recent U.S. data. But IVF ...

The gene-ie is out of the bottle. A fertility startup that offers embryo screening to predict a baby’s height and intelligence has sparked controversy with a series of provocative new ads. Nucleus ...

Survey reveals nearly three-quarters of U.S. adults support using emerging technology to screen embryos during IVF for risk of developing certain health conditions or traits that arise from more than ...